Protocol Ledger

NCT07776522 · Phase II · RECRUITING

Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

Interventional Phase II clinical trial protocol NCT07776522 sponsored by West China Hospital in Ophthalmology and Sensory, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-08-31 Enrollment: 50 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07776522
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)50 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07776522
Protocol FieldVerified Registry Value
NCT IdentifierNCT07776522
Consolidated Lead SponsorWest China Hospital
Therapeutic Condition CohortOphthalmology and Sensory
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment50 participants (ESTIMATED)
Registered Start Date2026-08-31
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI